Fulgent Genetics Reports Record First Quarter Financial Results

Go back to Fulgent Genetics Reports Record First Quarter Financial Results

Fulgent Genetics, Inc. (FLGT) Tops Q1 EPS by 73c; Raises Outlook

May 6, 2021 4:07 PM EDT

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q1 EPS of $6.59, $0.73 better than the analyst estimate of $5.86. Revenue for the quarter came in at $359.4 million versus the consensus estimate of $321.51 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2021 EPS of $12.50, versus the consensus of... More